Manipulation of immune responses by Epstein–Barr virus
- 30 September 2002
- journal article
- review article
- Published by Elsevier BV in Virus Research
- Vol. 88 (1-2), 71-86
- https://doi.org/10.1016/s0168-1702(02)00121-1
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Epstein–Barr virus primes human polymorphonuclear leucocytes for the biosynthesis of leukotriene B4Clinical and Experimental Immunology, 2001
- GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorderJCI Insight, 2001
- Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha SecretionJournal of Virology, 2000
- Binding of the epstein-barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-α gene expression in monocytic cells via NF-κb involving PKC, PI3-K and tyrosine kinasesJournal of Molecular Biology, 2000
- T Helper Cell Type 1–associated and Cytotoxic T Lymphocyte–mediated Tumor Immunity Is Impaired in Interleukin 4–deficient MiceThe Journal of Experimental Medicine, 1999
- Adenovirus early region 1A protein binds to mammalian SUG1-a regulatory component of the proteasomeOncogene, 1999
- Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and RecyclingImmunity, 1997
- HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + PopulationScience, 1993
- Expression of Interleukin-10 Activity by Epstein-Barr Virus Protein BCRF1Science, 1990
- A non-X-linked syndrome with susceptibility to severe epstein-barr virus infectionsThe Journal of Pediatrics, 1982